Efficacy and safety of PD-1 inhibitors combined with anti-angiogenic agents in patients with recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis
In summary, PD-1 inhibitors combined with anti-angiogenic agents exhibited notable effectiveness with a manageable safety profile. Additional phase III randomized controlled trials (RCTs) are needed to confirm these findings.
Authors
- Xia He (ORCID: https://orcid.org/0000-0002-7314-1002)
- Jingjing Gao (ORCID: https://orcid.org/0000-0003-4226-3944)
- Jingshu Xu (ORCID: https://orcid.org/0000-0002-0130-348X)
- Dan Zong (ORCID: https://orcid.org/0000-0003-4984-4557)
- Yiyue He
Institutions
- Xuzhou Medical College (CN)
- Jiangsu Cancer Hospital (CN)
- Second Affiliated Hospital of Nanjing Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1007/s12672-025-04049-y
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00